Cook Wealth LLC Has $342,000 Holdings in Simulations Plus, Inc. $SLP

Cook Wealth LLC grew its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 12.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,960 shares of the technology company’s stock after acquiring an additional 1,574 shares during the period. Cook Wealth LLC’s holdings in Simulations Plus were worth $342,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Conestoga Capital Advisors LLC lifted its position in Simulations Plus by 17.2% during the first quarter. Conestoga Capital Advisors LLC now owns 2,609,388 shares of the technology company’s stock worth $63,982,000 after acquiring an additional 383,126 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in shares of Simulations Plus by 16.7% during the fourth quarter. Ameriprise Financial Inc. now owns 607,902 shares of the technology company’s stock worth $16,954,000 after purchasing an additional 86,868 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Simulations Plus by 7,753.3% during the fourth quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company’s stock worth $15,141,000 after purchasing an additional 535,986 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Simulations Plus by 6.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 419,241 shares of the technology company’s stock worth $11,693,000 after purchasing an additional 24,266 shares during the period. Finally, Northern Trust Corp increased its holdings in shares of Simulations Plus by 10.0% during the fourth quarter. Northern Trust Corp now owns 236,373 shares of the technology company’s stock worth $6,592,000 after purchasing an additional 21,453 shares during the period. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently commented on SLP. BTIG Research lowered their target price on shares of Simulations Plus from $41.00 to $25.00 and set a “buy” rating on the stock in a report on Monday, July 7th. JMP Securities reaffirmed a “market perform” rating on shares of Simulations Plus in a report on Wednesday, June 18th. Stephens lowered their target price on shares of Simulations Plus from $28.00 to $20.00 and set an “overweight” rating on the stock in a report on Tuesday, July 15th. Craig Hallum lowered their target price on shares of Simulations Plus from $45.00 to $36.00 and set a “buy” rating on the stock in a report on Friday, June 13th. Finally, Zacks Research raised shares of Simulations Plus to a “hold” rating in a report on Tuesday, August 12th. Four analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Simulations Plus has a consensus rating of “Moderate Buy” and an average target price of $26.50.

Simulations Plus Price Performance

Shares of Simulations Plus stock opened at $14.38 on Thursday. Simulations Plus, Inc. has a fifty-two week low of $12.39 and a fifty-two week high of $37.67. The firm has a market capitalization of $289.47 million, a P/E ratio of -4.57 and a beta of 0.85. The company’s 50 day moving average price is $14.67 and its two-hundred day moving average price is $23.63.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Monday, July 14th. The technology company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.19. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 11.62%. The firm had revenue of $20.36 million for the quarter, compared to analyst estimates of $22.83 million. During the same quarter last year, the business posted $0.27 earnings per share. The company’s quarterly revenue was up 9.8% on a year-over-year basis. On average, analysts expect that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.